BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 9866452)

  • 1. Pulse vaccination strategy in the SIR epidemic model.
    Shulgin B; Stone L; Agur Z
    Bull Math Biol; 1998 Nov; 60(6):1123-48. PubMed ID: 9866452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The social impact of the vaccination against measles in Mexico. Comments during the course of the epidemics of 1988-1990].
    Cárdenas-Ayala VM; Sánchez-Vargas C
    Bol Med Hosp Infant Mex; 1990 Jul; 47(7):500-5. PubMed ID: 2206416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination in pulses: a strategy for global eradication of measles and polio?
    Nokes DJ; Swinton J
    Trends Microbiol; 1997 Jan; 5(1):14-9. PubMed ID: 9025230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An analysis of the effect of measles vaccination program by a mathematical model].
    Kakehashi M
    Nihon Koshu Eisei Zasshi; 1990 Jul; 37(7):481-90. PubMed ID: 2132377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal treatment of an SIR epidemic model with time delay.
    Zaman G; Kang YH; Jung IH
    Biosystems; 2009 Oct; 98(1):43-50. PubMed ID: 19464340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A link between the North Atlantic Oscillation and measles dynamics during the vaccination period in England and Wales.
    Lima M
    Ecol Lett; 2009 Apr; 12(4):302-14. PubMed ID: 19292792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global eradication of measles: an epidemiologic and economic evaluation.
    Levin A; Burgess C; Garrison LP; Bauch C; Babigumira J; Simons E; Dabbagh A
    J Infect Dis; 2011 Jul; 204 Suppl 1():S98-106. PubMed ID: 21666220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [An economic evaluation of measles vaccination in District 3 of the city of Bucharest].
    Ion-Nedelcu N; Mihăileanu C; Dobrescu A
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1989; 34(2):163-8. PubMed ID: 2506626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late vaccination reinforcement during a measles epidemic in Niamey, Niger (2003-2004).
    Dubray C; Gervelmeyer A; Djibo A; Jeanne I; Fermon F; Soulier MH; Grais RF; Guerin PJ
    Vaccine; 2006 May; 24(18):3984-9. PubMed ID: 16540214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategic planning for measles control: using data to inform optimal vaccination strategies.
    Simons E; Mort M; Dabbagh A; Strebel P; Wolfson L
    J Infect Dis; 2011 Jul; 204 Suppl 1():S28-34. PubMed ID: 21666174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seasonally varying epidemics with and without latent period: a comparative simulation study.
    Moneim IA
    Math Med Biol; 2007 Mar; 24(1):1-15. PubMed ID: 17317756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Finding optimal vaccination strategies under parameter uncertainty using stochastic programming.
    Tanner MW; Sattenspiel L; Ntaimo L
    Math Biosci; 2008 Oct; 215(2):144-51. PubMed ID: 18700149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of using different types of periodic contact rate on the behaviour of infectious diseases: a simulation study.
    Moneim IA
    Comput Biol Med; 2007 Nov; 37(11):1582-90. PubMed ID: 17452036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling the impact of vaccination strategies.
    Wallinga J
    Neth J Med; 2002 Aug; 60(7 Suppl):67-75; discussion 76-7. PubMed ID: 12430593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple dose vaccination against childhood diseases: high coverage with the first dose remains crucial for eradication.
    Paulo AC; Gomes MC; Casinhas AC; Horta A; Domingos T
    IMA J Math Appl Med Biol; 2000 Sep; 17(3):201-12. PubMed ID: 11103718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles eradication in the Americas: experience in Haiti.
    Venczel L; Dobbins J; André J; Laender F; Izurieta H; Delorme P; Voltaire HC
    J Infect Dis; 2003 May; 187 Suppl 1():S127-32. PubMed ID: 12721903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using cost-effectiveness analysis to support research and development portfolio prioritization for product innovations in measles vaccination.
    Garrison LP; Bauch CT; Bresnahan BW; Hazlet TK; Kadiyala S; Veenstra DL
    J Infect Dis; 2011 Jul; 204 Suppl 1():S124-32. PubMed ID: 21666153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Measles epidemiology in the Netherlands: a exploratory analysis of notification].
    Wallinga J; van den Hof S
    Ned Tijdschr Geneeskd; 2000 Jan; 144(4):171-4. PubMed ID: 10668543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating transmission intensity for a measles epidemic in Niamey, Niger: lessons for intervention.
    Grais RF; Ferrari MJ; Dubray C; Bjørnstad ON; Grenfell BT; Djibo A; Fermon F; Guerin PJ
    Trans R Soc Trop Med Hyg; 2006 Sep; 100(9):867-73. PubMed ID: 16540134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of targeted urban supplemental measles vaccination campaigns (1997-1999) to prevent measles epidemics in Mozambique (1998-2001).
    Cliff J; Simango A; Augusto O; Van Der Paal L; Biellik R
    J Infect Dis; 2003 May; 187 Suppl 1():S51-7. PubMed ID: 12721891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.